PubRank

Ross I Baker

Author PubWeight™ 26.98‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 2003 11.00
2 Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism. J Clin Oncol 2005 3.42
3 Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia B. N Engl J Med 2013 1.40
4 Avoiding adverse events with dabigatran by careful selection of eligible patients. Med J Aust 2012 1.39
5 Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy. Br J Haematol 2013 1.30
6 Endothelial and platelet activation in acute ischemic stroke and its etiological subtypes. Stroke 2003 1.16
7 Dual ITAM-mediated proteolytic pathways for irreversible inactivation of platelet receptors: de-ITAM-izing FcgammaRIIa. Blood 2007 1.06
8 C-reactive protein in ischemic stroke and its etiologic subtypes. J Stroke Cerebrovasc Dis 2007 0.93
9 Once-daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep-vein thrombosis. J Thromb Thrombolysis 2005 0.88
10 Soluble glycoprotein VI is raised in the plasma of patients with acute ischemic stroke. Stroke 2010 0.85
11 A consensus statement on the management of pregnancy and delivery in women who are carriers of or have bleeding disorders. Med J Aust 2009 0.85
12 A novel ABCA1 nonsense mutation, R1270X, in Tangier disease associated with an unrecognised bleeding tendency. Clin Chim Acta 2009 0.82
13 Long-term safety and efficacy of extended-interval prophylaxis with recombinant factor IX Fc fusion protein (rFIXFc) in subjects with haemophilia B. Thromb Haemost 2016 0.81
14 Venous thromboembolism in travellers: can we identify those at risk? Blood Coagul Fibrinolysis 2003 0.77
15 Polymorphisms in the tissue factor pathway inhibitor gene are not associated with ischaemic stroke. Blood Coagul Fibrinolysis 2007 0.75
16 Polymorphisms of the tissue factor pathway inhibitor gene are associated with venous thromboembolism in the antiphospholipid syndrome and carriers of factor V Leiden. Blood Coagul Fibrinolysis 2007 0.75
17 Prevention of recurrent thrombosis in the antiphospholipid antibody syndrome: how long and how high with oral anticoagulant therapy? Med J Aust 2004 0.75
18 Restored platelet function after romiplostim treatment in a patient with immune thrombocytopenic purpura. Br J Haematol 2010 0.75